Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Novo Nordisk presents new analogues of fibroblast growth factor 21

Jan. 13, 2012

Phase III data disclosed on Technosphere Insulin versus usual care for diabetes

Jan. 13, 2012

EC adopts opinion on pioglitazone-containing drugs

Jan. 12, 2012

Lexicon Pharmaceuticals reports topline data from LX-4211/sitagliptin combination trial

Jan. 12, 2012

Isis Pharmaceuticals reports phase I data on ISIS-TTRRx

Jan. 12, 2012

KalVista Pharmaceuticals and JDRF enter partnership

Jan. 11, 2012

Amicus Therapeutics presents results from phase II study in Fabry's disease

Jan. 11, 2012

BioCryst reports on extension phase of BCX-4208 trial

Jan. 11, 2012

Alnylam files ALN-TTR02 CTA with MHRA

Jan. 10, 2012

Phase II trial of diabetes vaccine reaches full enrollment

Jan. 10, 2012

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...